BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1293 related articles for article (PubMed ID: 26499846)

  • 1. Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression.
    Li Z; Zhang H
    Cell Mol Life Sci; 2016 Jan; 73(2):377-92. PubMed ID: 26499846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Mitochondrial Fat Oxidation in Cancer Cell Proliferation and Survival.
    De Oliveira MP; Liesa M
    Cells; 2020 Dec; 9(12):. PubMed ID: 33291682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma.
    Pang Y; Lu T; Xu-Monette ZY; Young KH
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic reprogramming as a feast for virus replication.
    Polcicova K; Badurova L; Tomaskova J
    Acta Virol; 2020; 64(2):201-215. PubMed ID: 32551788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parallels between embryo and cancer cell metabolism.
    Smith DG; Sturmey RG
    Biochem Soc Trans; 2013 Apr; 41(2):664-9. PubMed ID: 23514173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SnapShot: Cancer metabolism.
    Brunner JS; Finley LWS
    Mol Cell; 2021 Sep; 81(18):3878-3878.e1. PubMed ID: 34547243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic targeting of cancers: from molecular mechanisms to therapeutic strategies.
    Sheng H; Niu B; Sun H
    Curr Med Chem; 2009; 16(13):1561-87. PubMed ID: 19442134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The roles of sirtuins family in cell metabolism during tumor development.
    Zhu S; Dong Z; Ke X; Hou J; Zhao E; Zhang K; Wang F; Yang L; Xiang Z; Cui H
    Semin Cancer Biol; 2019 Aug; 57():59-71. PubMed ID: 30453040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism.
    Judge A; Dodd MS
    Essays Biochem; 2020 Oct; 64(4):607-647. PubMed ID: 32830223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression.
    Vaupel P; Schmidberger H; Mayer A
    Int J Radiat Biol; 2019 Jul; 95(7):912-919. PubMed ID: 30822194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial and metabolic alterations in cancer cells.
    Di Gregorio J; Petricca S; Iorio R; Toniato E; Flati V
    Eur J Cell Biol; 2022; 101(3):151225. PubMed ID: 35453093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose Addiction in Cancer Therapy: Advances and Drawbacks.
    Granja S; Pinheiro C; Reis RM; Martinho O; Baltazar F
    Curr Drug Metab; 2015; 16(3):221-42. PubMed ID: 26504932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting metabolic reprogramming in KRAS-driven cancers.
    Kawada K; Toda K; Sakai Y
    Int J Clin Oncol; 2017 Aug; 22(4):651-659. PubMed ID: 28647837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reprogramming of Metabolism in Kidney Cancer.
    Wettersten HI
    Semin Nephrol; 2020 Jan; 40(1):2-13. PubMed ID: 32130963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of microRNAs in metabolic reprogramming of breast cancer.
    Feng F; Yu Q; Zhang F
    J Pak Med Assoc; 2022 Feb; 72(2):312-316. PubMed ID: 35320184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic Reprogramming in COVID-19.
    Shen T; Wang T
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the Warburg effect: the metabolic requirements of cell proliferation.
    Vander Heiden MG; Cantley LC; Thompson CB
    Science; 2009 May; 324(5930):1029-33. PubMed ID: 19460998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic Pathways, Enzymes, and Metabolites: Opportunities in Cancer Therapy.
    Kumar R; Mishra A; Gautam P; Feroz Z; Vijayaraghavalu S; Likos EM; Shukla GC; Kumar M
    Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer cell metabolism and mitochondria: Nutrient plasticity for TCA cycle fueling.
    Corbet C; Feron O
    Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):7-15. PubMed ID: 28110019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mTOR signalling and cellular metabolism are mutual determinants in cancer.
    Mossmann D; Park S; Hall MN
    Nat Rev Cancer; 2018 Dec; 18(12):744-757. PubMed ID: 30425336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.